Search

Author/Creator Lin, Tara L

1. CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial. Issue 7 (July 2021)

Authors:
Lancet, Jeffrey E; Uy, Geoffrey L; Newell, Laura F; Lin, Tara L; Ritchie, Ellen K; Stuart, Robert K; Strickland, Stephen A; Hogge, Donna; Solomon, Scott R; Bixby, Dale L; Kolitz, Jonathan E; Schiller, Gary J; Wieduwilt, Matthew J; Ryan, Daniel H; Faderl, Stefan; Cortes, Jorge E
Journal:
Lancet
Issue:
Volume 8:Issue 7(2021)
Page Start:
e481
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search